Clinical Coagulation, Malmö
281 – 290 of 630
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity
(
- Contribution to journal › Article
-
Mark
The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Red cell distribution width and risk for venous thromboembolism: A population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?
(
- Contribution to journal › Article
-
Mark
Atrial fibrillation patients do not benefit from acetylsalicylic acid
(
- Contribution to journal › Article
-
Mark
A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network.
(
- Contribution to journal › Letter
-
Mark
Managing Haemophilia for Life: 4th Haemophilia Global Summit
(
- Contribution to journal › Scientific review
-
Mark
Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.
(
- Contribution to journal › Article
-
Mark
Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review
(
- Contribution to journal › Scientific review
-
Mark
Angiogenesis is increased in advanced haemophilic joint disease and characterized by normal pericyte coverage.
(
- Contribution to journal › Article